| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Biolife Solutions, Inc.'s insiders have reduced their positions by a net 1,200,000 shares worth roughly $28.1M.
Classified under Health Care Equipment & Supplies (Health Care sector), BLFS's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 4.76M | $164.88M | - | |
| CEO | 733.7K | $25.43M | - | |
| VP | 388.5K | $13.46M | - | |
| CFO | 213.2K | $7.39M | - | |
| Other | 162.6K | $5.64M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Phillips Geraint | SVP, Global Operations | Sell | 131 | $17.35 | $2,272.85 | -0.2% | +23.9% | +57.2% | |
| Feb 21, 2024 | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 58 | $17.35 | $1,006.30 | -0.1% | +23.9% | +57.2% | |
| Feb 21, 2024 | Berard Todd67 | Chief Marketing Officer | Sell | 111 | $17.35 | $1,925.85 | - | +23.9% | +57.2% | |
| Feb 21, 2024 | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 101 | $17.35 | $1,752.35 | - | +23.9% | +57.2% | |
| Feb 21, 2024 | Foster Karen A.67 | Chief Quality And Operations | Sell | 87 | $17.35 | $1,509.45 | - | +23.9% | +57.2% | |
| Jan 23, 2024 | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 336 | $17.11 | $5,748.96 | -0.8% | -3.7% | +57.5% | |
| Jan 19, 2024 | Foster Karen A.67 | Chief Quality And Operations | Sell | 1,198 | $16.76 | $20,078.48 | -1.0% | -7.6% | +52.2% | |
| Jan 19, 2024 | Phillips Geraint | SVP, Global Operations | Sell | 1,776 | $16.76 | $29,765.76 | -3.0% | -7.6% | +52.2% | |
| Jan 19, 2024 | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 1,450 | $16.76 | $24,302.00 | -0.5% | -7.6% | +52.2% | |
| Jan 19, 2024 | De Greef Roderick74 | President And CEO | Sell | 2,642 | $16.76 | $44,279.92 | -0.6% | -7.6% | +52.2% |